SeNostic Overview
- Founded
- 2016

- Status
- Private
- Employees
- 4

- Latest Deal Type
- Early Stage VC
- Investors
- 3
SeNostic General Information
Description
Operator of a diagnostics company intended to provide precise and accurate early differential diagnosis of multiple neurodegenerative disorders. The company's technologies provide biochemicals for neuroscience research and develop vitro diagnostic tests for neurodegenerative disorders as well as provides a unique way to amplify and characterize disease-specific protein aggregates present in tissues and body fluids, enabling patients to avail proper treatment for their disease.
Contact Information
- Feodor-Lynen-Straße 21
- 30625 Hannover
- Germany
SeNostic Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Early Stage VC | 29-May-2019 | Completed | Startup | |||
2. Seed Round | 25-Jan-2016 | Completed | Startup | |||
1. Seed Round | Completed | Startup |
SeNostic Executive Team (6)
SeNostic Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSeNostic Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
NBank Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg | Venture Capital | Minority | 000 0000 | 000000 0 |